EA202193344A1 - SAFE AND EFFECTIVE METHOD OF TREATMENT OF PSORIATIC ARTHRITIS WITH IL-23 SPECIFIC ANTIBODY - Google Patents
SAFE AND EFFECTIVE METHOD OF TREATMENT OF PSORIATIC ARTHRITIS WITH IL-23 SPECIFIC ANTIBODYInfo
- Publication number
- EA202193344A1 EA202193344A1 EA202193344A EA202193344A EA202193344A1 EA 202193344 A1 EA202193344 A1 EA 202193344A1 EA 202193344 A EA202193344 A EA 202193344A EA 202193344 A EA202193344 A EA 202193344A EA 202193344 A1 EA202193344 A1 EA 202193344A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- specific antibody
- psoriatic arthritis
- safe
- treatment
- effective method
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Способ лечения псориатического артрита у пациента путем введения специфического к ИЛ-23 антитела, например гуселькумаба, в клинически доказанном безопасном и клинически доказанном эффективном количестве, и указанный пациент достигает значительного улучшения по клиническим конечным показателям, таким как ACR20/50/70, IGA, HAQ-DI, СРБ, PCS/MCS SF-36, MDA, VLDA, энтезит, дактилит и LEI/дактилит, измеренные через 16 и 24 недели после начального лечения.A method of treating psoriatic arthritis in a patient by administering an IL-23 specific antibody, e.g., Guselcumab, in a clinically proven safe and clinically proven effective amount, and said patient achieves significant improvement in clinical endpoints such as ACR20/50/70, IGA, HAQ -DI, CRP, PCS/MCS SF-36, MDA, VLDA, enthesitis, dactylitis, and LEI/dactylitis measured at 16 and 24 weeks after initial treatment.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062993259P | 2020-03-23 | 2020-03-23 | |
PCT/IB2020/055278 WO2020245766A1 (en) | 2019-06-04 | 2020-06-04 | Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202193344A1 true EA202193344A1 (en) | 2022-03-14 |
Family
ID=81077510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202193344A EA202193344A1 (en) | 2020-03-23 | 2020-06-04 | SAFE AND EFFECTIVE METHOD OF TREATMENT OF PSORIATIC ARTHRITIS WITH IL-23 SPECIFIC ANTIBODY |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202193344A1 (en) |
-
2020
- 2020-06-04 EA EA202193344A patent/EA202193344A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014953A (en) | Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody. | |
EA201892190A1 (en) | TREATMENT OF PSORIASIS WITH ANTI-BODY TO IL-12 AND / OR IL-23 WITH THE GROWTH OF THE INTERVAL BETWEEN THE INTRODUCTION OF DOSE | |
MX2020004716A (en) | Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody. | |
MX2021001762A (en) | Method and composition for stimulating immune response. | |
AR091462A1 (en) | ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSAGE AND METHODS OF USE | |
JOP20200156A1 (en) | Esketamine for the treatment of depression | |
MX2019005661A (en) | Method of treating psoriasis with anti-il-23 specific antibody. | |
JP2018505882A5 (en) | ||
CL2021002533A1 (en) | Compositions and methods for treating diseases or disorders associated with kras | |
MX2019003703A (en) | Safe and effective method of treating psoriasis with anti-il23 specific antibody. | |
NZ744233A (en) | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack | |
FI13575Y1 (en) | IL12/IL23 antibody to be used in a safe and efficient method for treating ulcerative colitis | |
JP2020500152A5 (en) | ||
MX2020009265A (en) | Methods of treating crohn's disease with anti-il23 specific antibody. | |
EA202193344A1 (en) | SAFE AND EFFECTIVE METHOD OF TREATMENT OF PSORIATIC ARTHRITIS WITH IL-23 SPECIFIC ANTIBODY | |
BR112023018400A2 (en) | METHOD FOR TREATMENT OF PSORIATIC ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF THERAPY WITH SPECIFIC ANTI-IL23 ANTIBODY | |
WO2020079489A3 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
MX2022013923A (en) | Methods of treating crohn's disease with anti-il23 specific antibody. | |
RU2017100658A (en) | THERAPEUTIC AGAINST Helicobacter | |
EA202191947A1 (en) | METHODS FOR TREATING PAIN WITH THIAZOLINE ANTIHYPERALGESIC DRUG | |
BR112023018353A2 (en) | SAFE AND EFFECTIVE METHOD FOR TREATMENT OF PSORIATIC ARTHRITIS WITH SPECIFIC ANTI-IL23 ANTIBODY | |
MX2021005905A (en) | Safe and effective method of treating psoriasis with anti-il-23 specific antibody. | |
CL2023001201A1 (en) | Regimens for treatment of hair loss disorders with deuterated jak inhibitors | |
AR126578A1 (en) | ANTI-CCR8 ANTIBODIES | |
EA202191423A1 (en) | SAFE AND EFFECTIVE METHOD FOR TREATMENT OF PSORIASIS WITH ANTIBODY SPECIFIC TO IL-23 |